BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16410654)

  • 1. Microglia activation in the brain as inflammatory biomarker of Alzheimer's disease neuropathology and clinical dementia.
    Xiang Z; Haroutunian V; Ho L; Purohit D; Pasinetti GM
    Dis Markers; 2006; 22(1-2):95-102. PubMed ID: 16410654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspase gene expression in the brain as a function of the clinical progression of Alzheimer disease.
    Pompl PN; Yemul S; Xiang Z; Ho L; Haroutunian V; Purohit D; Mohs R; Pasinetti GM
    Arch Neurol; 2003 Mar; 60(3):369-76. PubMed ID: 12633148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.
    Hallikainen I; Hänninen T; Fraunberg M; Hongisto K; Välimäki T; Hiltunen A; Karppi P; Sivenius J; Soininen H; Koivisto AM;
    Int Psychogeriatr; 2013 Aug; 25(8):1335-44. PubMed ID: 23676340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease.
    Dandrea MR; Reiser PA; Gumula NA; Hertzog BM; Andrade-Gordon P
    Biotech Histochem; 2001 Mar; 76(2):97-106. PubMed ID: 11440311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staining of HLA-DR, Iba1 and CD68 in human microglia reveals partially overlapping expression depending on cellular morphology and pathology.
    Hendrickx DAE; van Eden CG; Schuurman KG; Hamann J; Huitinga I
    J Neuroimmunol; 2017 Aug; 309():12-22. PubMed ID: 28601280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation mechanism of brain microglia in patients with diffuse neurofibrillary tangles with calcification: a comparison with Alzheimer disease.
    Imamura K; Sawada M; Ozaki N; Naito H; Iwata N; Ishihara R; Takeuchi T; Shibayama H
    Alzheimer Dis Assoc Disord; 2001; 15(1):45-50. PubMed ID: 11236824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia.
    Luterman JD; Haroutunian V; Yemul S; Ho L; Purohit D; Aisen PS; Mohs R; Pasinetti GM
    Arch Neurol; 2000 Aug; 57(8):1153-60. PubMed ID: 10927795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased densities of resting and activated microglia in the dentate gyrus follow senile plaque formation in the CA1 subfield of the hippocampus in the triple transgenic model of Alzheimer's disease.
    Rodríguez JJ; Noristani HN; Hilditch T; Olabarria M; Yeh CY; Witton J; Verkhratsky A
    Neurosci Lett; 2013 Sep; 552():129-34. PubMed ID: 23827221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathological diagnostic criteria for Alzheimer's disease.
    Murayama S; Saito Y
    Neuropathology; 2004 Sep; 24(3):254-60. PubMed ID: 15484705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down syndrome individuals with Alzheimer's disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer's disease.
    Wilcock DM; Hurban J; Helman AM; Sudduth TL; McCarty KL; Beckett TL; Ferrell JC; Murphy MP; Abner EL; Schmitt FA; Head E
    Neurobiol Aging; 2015 Sep; 36(9):2468-74. PubMed ID: 26103884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain.
    Styren SD; Civin WH; Rogers J
    Exp Neurol; 1990 Oct; 110(1):93-104. PubMed ID: 1698655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial immunophenotype in dementia with Alzheimer's pathology.
    Minett T; Classey J; Matthews FE; Fahrenhold M; Taga M; Brayne C; Ince PG; Nicoll JA; Boche D;
    J Neuroinflammation; 2016 Jun; 13(1):135. PubMed ID: 27256292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lewy body variant of Alzheimer's disease and Alzheimer's disease: a comparative immunohistochemical study.
    Szpak GM; Lewandowska E; Lechowicz W; Bertrand E; Wierzba-Bobrowicz T; Gwiazda E; Pasennik E; Kosno-Kruszewska E; Lipczyńska-Lojkowska W; Bochyńska A; Fiszer U
    Folia Neuropathol; 2001; 39(2):63-71. PubMed ID: 11680637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: a commentary.
    Mirra SS
    Neurobiol Aging; 1997; 18(4 Suppl):S91-4. PubMed ID: 9330994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive microglia in aging and dementia: an immunohistochemical study of postmortem human brain tissue.
    Overmyer M; Helisalmi S; Soininen H; Laakso M; Riekkinen P; Alafuzoff I
    Acta Neuropathol; 1999 Apr; 97(4):383-92. PubMed ID: 10208278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR.
    McGeer PL; Itagaki S; Tago H; McGeer EG
    Neurosci Lett; 1987 Aug; 79(1-2):195-200. PubMed ID: 3670729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stages of granulovacuolar degeneration: their relation to Alzheimer's disease and chronic stress response.
    Thal DR; Del Tredici K; Ludolph AC; Hoozemans JJ; Rozemuller AJ; Braak H; Knippschild U
    Acta Neuropathol; 2011 Nov; 122(5):577-89. PubMed ID: 21935637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors.
    Mattiace LA; Davies P; Dickson DW
    Am J Pathol; 1990 May; 136(5):1101-14. PubMed ID: 1693471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical dementia rating performed several years prior to death predicts regional Alzheimer's neuropathology.
    Schnaider Beeri M; Silverman JM; Schmeidler J; Wysocki M; Grossman HZ; Purohit DP; Perl DP; Haroutunian V
    Dement Geriatr Cogn Disord; 2008; 25(5):392-8. PubMed ID: 18367838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.